CELZ News and Press, Creative Medical Technology Holdings Inc. From 11/10/23

Yaskawa Electric Corporation ADR (YASKY) is expected to report for Q2 2024 Bank of China Ltd. ADR (BACHY) is expected to report for Q2 2024 Algonquin Power & Utilities Corp. (AQN) is expected to report $0.11 for Q3 2023 Soho House & Co Inc. Class A (SHCO) is expected to report...

Creative Medical Technology Holdings Inc. (CELZ) is expected to report $-0.86 for Q3 2023

2023-10-31 07:27:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday! We’re deep into earnings season with several companies r...

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain PR Newswire Company reaches next clinical trial milestone for t...

2023-09-19 14:08:24 ET More on Creative Medical Seeking Alpha’s Quant Rating on Creative Medical Technology Holdings, Inc. Historical earnings data for Creative Medical Technology Holdings, Inc. Financial information for Creative Medical Technology Holdings, I...

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain PR Newswire PHOENIX , Sept. 19, 2023 /PRNewswire/ -- Creative Me...

2023-09-13 08:17:11 ET Creative Medical Technology  ( NASDAQ: CELZ ) +17% . Rocket Pharmaceuticals ( RCKT ) +24% rises as FDA supports accelerated path for gene therapy. Mainz Biomed  ( MYNZ ) +16% Study, Evaluating its Novel mRNA Biomarkers, Re...

PHOENIX, AZ / ACCESSWIRE / August 24, 2023 / Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) seems to be witnessing success in the allogeneic cell therapy market. In Q4 2022, the company - best known for its regenerative approach to immunotherapy, endocrin...

PHOENIX, AZ / ACCESSWIRE / July 14, 2023 / Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this type of manipulation has been associated with cancer ...

PHOENIX, AZ / ACCESSWIRE / July 13, 2023 / Creative Medical Technology Holdings, Inc. ("Creative Medical Technology") (NASDAQ:CELZ) recently released an update on their drug pipeline and financial standing going into Q3 2023. The biotechnology company is known for its regenerative approach to im...